Sakura Bio
Business Services · 1-10 Employees
View Company Info for Free
Overview
Website
www.sakurabio.comRevenue
$6.4 MillionIndustry
About Sakura Bio
Sakura Bio is a start-up biotech company focused on developing off-the-shelf, allogeneic T-cell therapies to combat cancer. Their lead product, Skill therapy, features a unique T-cell population that exhibits enhanced anti-tumor activity without harming healthy tissue. The company aims to pioneer the future of cancer treatment by creating effective, durable, and accessible T and NK cell therapies. Their innovative technology enhances the potency and resistance of reprogrammed T and NK cells, addressing key limitations of existing therapies.Explore more
Sakura Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Sakura Bio Tech Stack
A closer look at the technologies used by Sakura Bio
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sakura Bio
Sign Up For FreeTo access detailed company insights
Sakura Bio is a start-up biotech company focused on developing off-the-shelf, allogeneic T-cell therapies to combat cancer. Their lead product, Skill therapy, features a unique T-cell population that exhibits enhanced anti-tumor activity without harming healthy tissue. The company aims to pioneer the future of cancer treatment by creating effective... Read More
